Medscape is available in 5 Language Editions – Choose your Edition here.


Acquired Epileptic Aphasia Clinical Presentation

  • Author: Eli S Neiman, DO; Chief Editor: Amy Kao, MD  more...
Updated: Dec 09, 2015


In this section, the following aspects of acquired epileptic aphasia (AEA) will be briefly discussed:

  • Language symptoms
  • Seizures
  • Behavioral and neuropsychologic disturbances
  • Controversial features

Language symptoms

The first manifestation of the language problem is often word deafness or auditory verbal agnosia. In many patients, auditory verbal agnosia may include lack of recognition of familiar noises; however, alert responses to sound and tonal audiograms are usually normal. In some patients, even the capability of lateralizing and/or localizing sound may be impaired.

Receptive language is often severely or profoundly impaired as a result of an interference with phonologic decoding. Although the primary problem is in the receptive sphere, this syndrome appears in a critical period of language acquisition; therefore, speech production may be affected just as badly as or even worse than language comprehension. This is often the case as the disease progresses.

In some cases, impairment may be most severe in expressive language. In one study, the aphasia was predominantly expressive in 6 of 77 patients who appeared to have AEA.

Reading and writing may be remarkably preserved in children with little speech or auditory comprehension, and these children can be taught lip reading and writing as well. Speech disturbances may include fluent aphasia, use of jargon and paraphasias, asyntaxia, and verbal stereotypies in children who are not completely mute. Some abnormalities may superficially resemble autism or psychosis, common diagnoses given to children with acquired epileptic aphasia.

The age of onset of aphasia is between 18 months and 13 years, but it is usually after 4 years and before 7 years. A few authors include in the definition of acquired epileptic aphasia patients with limited or no language development associated with paroxysmal electroencephalography (EEG). In such cases, being certain about the true age of onset of symptoms is difficult. Other authors have included cases of developmental dysphasia associated with seizure-related fluctuations in speech performance with acquired epileptic aphasia, whereas other authors have not. Further studies are necessary to determine if the response to treatment really differs to justify this separation.

Language deterioration commonly occurs over weeks or months, but acute onset after a seizure has also been described. Intermittent/episodic aphasia may be seen as well. Regarding the course of language dysfunction and its relationship with paroxysmal EEG abnormalities, no consensus exists concerning the relationship between discharges on the EEG and the presence and intensity of language problems. In many cases, continuous spike and wave during sleep seems to precede language deterioration, and improvement in the paroxysmal EEG pattern during sleep often precedes the clinical language improvement.

Several authors have found that aphasia is correlated with unilateral or bilateral temporal-lobe discharges or with periods of 1 or more years of continuous spike and wave of slow-wave sleep (CSWS) when language appears to worsen.[19] Other investigators found this correlation to be far from reliable. Soprano et al observed persistent EEG abnormalities in patients with poor language recovery, but 6 of 9 with EEG normalization remained aphasic.[11]

The relationship between aphasia and paroxysmal EEG may not be an "on-off" response. Several factors limit the reliability of the EEG data. Neurologic deficits do not closely follow the maximal EEG changes in time. Patients with unilateral motor weakness related to a seizure (Todd paralysis) often remain weak for hours, and in rare cases, days after a partial seizure is gone. Repeated and long seizures are most often associated with long postictal dysfunction, which, at some point, may not recover completely.

The assumptions that paroxysmal EEG may or may not be correlated with the aphasia fluctuation also may be flawed, because if epileptic and/or neurotoxic brain damage is present in acquired epileptic aphasia, recovery from this damage may take time or may never happen. Two findings—that some patients improve with the use of corticosteroids or adrenocorticotropin hormone (ACTH) and that patterns on angiograms resemble those seen in cerebral arteritis—suggest that inflammation and vasospasm may play a role in some cases of acquired epileptic aphasia. This phenomenon is probably not universal, because not all patients show EEG or clinical response to steroids, and 2 neuropathologic specimens from temporal lobectomies revealed no inflammatory changes.


The prevalence of clinical seizures in acquired epileptic aphasia is 70-85%. In one third of patients, only a single seizure (or episode of status epilepticus) is recorded. In about one half of affected children, a seizure is the initial manifestation of acquired epileptic aphasia. In some, a few years may pass between the first seizure and the onset of any speech problems, whereas the opposite is true in others. Seizures usually appear between ages 4 and 10 years, and many series show that remission of the seizures before adulthood (often before age 15 y) is the rule.

Clinical seizures are often easy to treat, but normalization of EEG discharges can be challenging. Among patients in whom ictal semiology is well described, 59% had partial seizures, 39% had generalized tonic-clonic seizures, and 16% had atypical absences. Myoclonic seizures involving the face and eyes have been described. About 12% of patients have a family history of epilepsy.

Behavioral and neuropsychologic disturbances

Behavioral disturbances are seen in as many as 78% of the patients. Some children may appear deaf or autistic. The diagnosis of autism is often considered because of the common presence of asyntaxia, parapsias, and verbal stereotypies. Hyperactivity and a decreased attention span are observed in as many as 80% of patients. Aggressive and oppositional behavior, including rage attacks, is not unusual. The aggression and rage may be so prominent that the patients may be admitted to a psychiatric service rather than a neurologic service, either initially or during the course of the disease. Anxiety and avoidant or bizarre behavior may also be seen.

Although behavior patterns are thought to be secondary to the language impairment in acquired epileptic aphasia, some patients may have complex, hard-to-explain, and bizarre behaviors, such as avoidance of interpersonal contact and gestural stereotypies. In some cases, frankly psychotic behavior has been described.

Other aspects of cognition are traditionally said to be preserved, but a discrepancy between nonverbal and verbal skills is sometimes seen. Diffuse neuropsychologic deficits may appear over time. Short-term memory is a debilitating feature seen in long-standing cases of acquired epileptic aphasia.

Controversial features

Some cases initially thought to be benign childhood epilepsy with centrotemporal spikes later develop into a picture of acquired epileptic aphasia. In addition, some patients with early onset benign childhood occipital epilepsy (Panayiotopoulos type) syndrome may have language dysfunction because of the continuous spike-and-wave discharges during slow-wave sleep.[20, 21]


Physical Examination

Mental status examination of patients with acquired epileptic aphasia (AEA) demonstrates language, speech, and behavior problems, as described earlier (see History). A history of a poor understanding of spoken language should be substantiated by performing objective testing of all aspects of the patient's speech and language, such as the child's comprehension, repetition, reading, and writing. Bedside and/or office testing of language skills should be supplemented by formal neuropsychologic testing.

Besides language, speech, and behavior, physical and neurologic examination of patients with acquired epileptic aphasia shows motor clumsiness or, less frequently, apraxia. In some cases, frank abnormalities of tone and motor function are noted, but these findings are the exceptions rather than the rule.

Patients with acquired epileptic aphasia secondary to a tumor, stroke, or head injury commonly have hemiparesis (usually right sided). Signs of increased intracranial pressure, such as papilledema and, in more extreme cases, erratic respirations, bradycardia, and hypertension, should alert the clinician to the possibility of a mass lesion.


Syndromes Related to AEA

This section will discuss the following (see also Diagnostic Considerations in the Differentials section):

  • Oromotor-expressive language deficit associated with a centrotemporal epileptic focus (acquired expressive epileptic aphasia)
  • Developmental dysphasia or developmental expressive language disorder
  • Acquired epileptic aphasia [AEA] and autism
  • AEA and ESES
  • Childhood disintegrative disorder

Oromotor-expressive language deficit associated with a centrotemporal epileptic focus (acquired expressive epileptic aphasia)

A rare syndrome has been described in which patients appear to have a primarily expressive language deficit associated with a centrotemporal epileptic focus. Temporary speech and oromotor disturbances may be seen in this syndrome, and voluntary oromotor functions and speech production may be affected depending on the location and spread of the epileptic discharges (more anterior or posterior in the perisylvian region). Similar to acquired epileptic aphasia, these deficits can occur as initial symptoms of the disorder without visible seizures. The range of symptoms in these patients goes from nonlinguistic deficits, such as intermittent drooling to oromotor apraxia, disfluency, and (in severe cases) full-blown anterior opercular syndrome.

Oromotor apraxia and speech problems may be congenital, or they may develop or worsen with episodes of sustained spike and wave discharges during sleep. Seizures are nocturnal and either orofaciobrachial partial or secondarily generalized. The ages of onset, progression, and recovery of the deficits are variable but depend on the degree and duration of epileptic activity. The electroencephalogram (EEG) in this syndrome shows rolandic (ie, centrotemporal) discharges, which are commonly bilateral.

During sleep, continuous spike and wave discharges may be seen on the EEG, and that pattern may be correlated with clinical deterioration. One family with this syndrome had autosomal dominant transmission with anticipation for the seizure disorder, oral and/or speech dyspraxia, and cognitive dysfunction, raising the possibility of a triplet repeat syndrome.[22] Antiepileptic medication and other agents (see Treatment), may affect the course of the disease in some cases.

Developmental dysphasia or developmental expressive language disorder

Developmental dysphasia is a syndrome in which language acquisition does not occur despite normal intelligence and the lack of brain or hearing pathology. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) refers to this syndrome as developmental expressive language disorder, a more appropriate term than developmental dysphasia, because it considers the poor development or lack of acquisition of expressive language.

Overnight sleep recording in patients with developmental dysphasia may show epileptiform discharges; in one study, as many as 30 of 32 cases studied had these discharges even though half of the patients studied never had a seizure. The EEG abnormalities in developmental dysphasia may be more prominent during sleep, but a study found only minimal or no worsening in the transition from sleep stages 1-2 to 3 (slow-wave sleep).

Other investigators have described patients with developmental expressive language disorder and epileptiform EEGs, which suggests that these cases are "congenital variants of the Landau-Kleffner syndrome (AEA)." As can be concluded from the name of this disorder, the main problem is with expressive language, whereas in classic acquired epileptic aphasia the primary problem is in the receptive sphere. Nonetheless, differentiation between this disorder and acquired epileptic aphasia may be difficult for the following reasons:

  • In acquired epileptic aphasia, the primary problem is in the receptive sphere, but speech production may be affected just as badly or even worse than language comprehension.
  • An expressive-aphasia variant of acquired epileptic aphasia is known.
  • Cases of acquired epileptic aphasia and developmental dysphasia can be seen in the same pedigree, including a report of discordant monozygotic twins, suggesting a similar genetic abnormality with different phenotypes. [2]
  • Many patients with developmental dysphasia also have EEG abnormalities, and 3 cases seemed to respond to adrenocorticotropin hormone (ACTH) therapy.

Because of these arguments, clinicians should be open to the possibility that some patients with developmental expressive language disorder may have abnormal EEGs and that they occasionally respond to treatments used for acquired epileptic aphasia. Differentiation of developmental expressive language disorder (developmental dysphasia) and acquired expressive epileptic aphasia (oromotor-expressive language deficit associated with centrotemporal epileptic focus) with an early onset of symptoms is difficult and may be impossible in many cases.

AEA and autism

Autism is a strong consideration in patients presenting with an acquired epileptic aphasia-like picture. Not all patients with acquired epileptic aphasia have seizures, and some patients with autism may have EEG abnormalities with or without seizures. As mentioned earlier, many families change their perception of the patient's history over time. In these cases, consulting the child's initial medical records to obtain the correct information is helpful. In that sense, retrospective analysis, especially if the initial consultation notes are not accessible, may overestimate the incidence of language regression in these patients.

The diagnosis of autism (autistic disorder) based on criteria of the DSM-IV-TR is divided in 3 subgroups: (1) impairment of reciprocal social interaction, (2) qualitative impairment in verbal and nonverbal communication as well as imaginative activity, and (3) markedly restrictive repertoire of activities and interests. Pervasive developmental disorder (PDD) is diagnosed when qualitative impairment of reciprocal social interaction and verbal and nonverbal communication skills is present without fulfillment of the criteria for autistic disorder, schizophrenia, or schizotypal or schizoid personality disorder.

A history of language regression is not unusual in autism and is obtained retrospectively in as many as 39% of children with autism and prospectively in one third of patients with either autism or PDD. Language regression occurs equally among children with autism or PDD with or without epilepsy. Children with low cognitive function are more likely to have undergone regression (34%) than those with better cognitive skills (20%). The age at which language regression occurs (ie, before or after 2 y) makes no difference in the proportion of children with epileptiform EEGs.

The frequency of overt epilepsy among patients with autism or PDD is 7.6-25%. This range partly depends on the definitions of autism and PDD and on how strictly these criteria are applied. Of these patients, epilepsy is more common among males, and the seizures start in the first year of life in more than 80% of the children. Tuchman and Rapin found that epilepsy was present in 14% of autistic children after they excluded patients with Rett syndrome.[23] Other authors have reported higher frequencies than this among patients with autism.

The relationship between autism, epileptiform EEG, epilepsy, and language regression is complex and only partially understood. In a study in which 60% of an autistic population underwent EEG, about 22% had epileptiform abnormalities. In approximately one half of the children in whom EEG demonstrated epileptiform discharges, the discharges were located over the centrotemporal region, regardless of whether the child was epileptic or had regression. Two explanations for this finding are possible: (1) Patients may have comorbidity of benign (rolandic) epilepsy with centrotemporal spike-EEG trait with autistic symptoms (eg, benign epilepsy with centrotemporal spikes, one of the most prevalent epileptic syndromes) or (2) There may be a cause-effect relationship between the epileptiform abnormalities and the autistic and language regression symptoms.

Tuchman and Rapin prospectively studied language regression in patients with PDD and found that, in nonepileptic autistic children, a history of regression was associated with a 2-fold increase in the incidence of epileptiform EEG compared with those who had not undergone regression and had no seizures.[23] The proportion of children with epilepsy or epileptiform EEGs who had regression before or after age 2 years did not differ.[23]

The types of seizures most commonly associated with autism are infantile spasms, complex partial seizures, and generalized tonic-clonic convulsions. About one third of autistic patients with epilepsy have (or had) infantile spasms or myoclonic seizures. Severe mental retardation and motor deficit appear to be associated with an increased incidence of epilepsy in autistic patients. A high incidence of epilepsy occurs in patients with deficit in oral comprehension or verbal auditory agnosia. This finding is not unexpected, because it is probably due to inclusion of patients with acquired epileptic aphasia and its variants, which all can demonstrate autistic features.


One of the main differential diagnoses of acquired epileptic aphasia is the syndrome of continuous spike-wave during slow sleep, or ESES. In fact, some authors consider acquired epileptic aphasia as part of the ESES spectrum. A few features may help differentiate these 2 syndromes, as follows:

  • In ESES, nocturnal spike and wave discharges by definition occupy more than 85% of slow-wave sleep (stages 3 non–rapid eye movement [NREM]), especially during the first sleep cycle, and become focal or disappear during REM sleep.
  • In acquired epileptic aphasia, generalized spike-and-wave discharges may continue to be maximal or may be seen only during REM.
  • The EEG in ESES may show frontal or frontocentral location of focal discharges, but in acquired epileptic aphasia the focal discharges often show temporal or parietal distribution.

The use of the source localization of the focal discharges for the differentiation of acquired epileptic aphasia from ESES has limited value, because well-documented ESES cases may have primary parietal generators for secondary generalized discharges. In many cases, the generalized discharges seen in ESES may represent secondary bilateral synchrony from a consistently unilateral focus, which can be located in either hemisphere. The seizures seen in patients with ESES are similar to the ones of acquired epileptic aphasia, but drop attacks and myoclonic and unilateral clonic seizures may be more common in ESES. The nature of the cognitive deterioration is more diffuse in ESES than in acquired epileptic aphasia.

Besides substantial language problems, patients often have reduced temporal-spatial orientation and memory function during the active phase of ESES. As measured by using the Wechsler intelligence scales for children (WISC), cognition (ie, intelligence quotient [IQ]) severely declines. Verbal scores on the WISC are affected more than performance scores. The term disintegrative epileptiform disorder has been used in reference to patients with normal development in whom deterioration of language, sociability, nonverbal communication, and cognition occurs after age 2 years in association with an epileptiform EEG, often with an ESES pattern.

Genetic factors in epileptic aphasias

Lesca et al found the following: "About 20% of cases of LKS, CSWS, and electroclinically atypical rolandic epilepsy are often associated with speech impairment and can have a genetic origin sustained by de novo or inherited mutation in the GRIN2A gene (encoding the N -methyl-D-aspartate (NMDA) glutamate receptor α2 subunit, GluN2A). The identification of GRIN2A as a major gene for these epileptic encephalopathies may provide crucial insights into the underlying pathophysiology."[24]

Rare pathogenic deletions that include GRIN2A can be implicated in neurodevelopmental disorders. Carvill et al found the following: "[They] sought to delineate the pathogenic role of GRIN2A in 519 probands with epileptic encephalopathies with diverse epilepsy syndromes. They identified 4 probands with GRIN2A variants that segregated with the disorder in their families. Notably, all 4 families presented with epileptic aphasia syndromes and accounted for 9% of epilepsy-aphasia cases. They did not detect pathogenic variants in GRIN2A in other epileptic encephalopathies (n = 475) or in probands with benign childhood epilepsy with centrotemporal spikes (n = 81)." They reported the first monogenic cause for epilepsy-aphasia. " GRIN2A mutations are restricted to this group of cases, which has important ramifications for diagnostic testing and treatment and provides new insights into the pathogenesis of this debilitating group of conditions."[25]

Childhood disintegrative disorder

Regression of language, cognition, and behavior after age 2 years has been classified as disintegrative disorder. The definition of the term is still evolving. Rapin suggested that the term disintegrative disorder should be used for patients with autistic regression with onset after age 2 years.[26, 27]

The DSM-IV-TR defines childhood disintegrative disorder as loss of language, social, adaptive, and play skills between the ages of 2 and 10 years after normal development in these areas before age 2 years. The DSM-IV-TR criteria require abnormal functioning in at least 2 of the following areas:

  • Social interaction
  • Verbal and nonverbal communication and make-believe play
  • Stereotyped behavior, interests, activities, mannerisms, and stereotypies

The DSM-IV-TR diagnostic criteria of childhood disintegrative disorder also require the clinician to rule out any of the other PDDs, schizophrenia, and other dementing medical conditions (eg, adrenoleukodystrophy, metachromatic leukodystrophy); however, the criteria do not specifically mention differentiation on the basis of EEG findings. The term disintegrative epileptiform disorder has been used to describe patients with normal development who present with deterioration of language, verbal and/or nonverbal communication, sociability, and cognition after age 2 years associated with an epileptiform EEG.

The EEG abnormality is often ESES with frontal predominance. The latter may be differentiated by widespread deterioration of cognition, as opposed to the picture of acquired epileptic aphasia, which affects mostly language, at times with secondary behavioral changes. Differentiation between disintegrative epileptiform disorder and ESES may be impossible on clinical and EEG grounds, owing to the variability of the behavioral and cognitive findings in ESES.

Table 2, below, summarizes the numbers of patients with abnormal EEG findings among autism, dysphasia, and epilepsy from studies by Tuchman and colleagues.

Table 2. Epileptiform EEG Findings in Autism, Dysphasia, and Epilepsy (Open Table in a new window)

Source Diagnosis Number of Patients Number of Patients with EEGs Patients with Abnormal EEGs (%)
Tuchman et al (1991) Autism with epilepsy 42 40 75
Autism without epilepsy 160 139 8
Dysphasia with epilepsy 19 19 58
Dysphasia without epilepsy 218 66 9
Tuchman and Rapin[23] (1997) PDD or autism 585 392* NA
With epilepsy NA 66 59
Without epilepsy NA 66 59
Without epilepsy but with history of regression NA 155 14
Without epilepsy and without history of regression NA 364 6
EEG(s) = electroencephalogram(s); NA = not applicable; PDD = personality developmental disorder.

* Sleep EEGs.

Contributor Information and Disclosures

Eli S Neiman, DO Neurologist and Clinical Neurophysiologist, Specialty Care, Inc; Assistant Professor of Neurology, Seton Hall University School of Health and Medical Sciences; Clinical Associate Professor of Neurology, Department of Neurology, Kansas City University of Medicine and Biosciences College of Osteopathic Medicine

Eli S Neiman, DO is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Osteopathic Association

Disclosure: Received honoraria from UCB Pharma for review panel membership; Received honoraria from UCB Pharma for speaking and teaching; Received honoraria from Cyberonics, Inc for speaking and teaching.


Michael Seyffert, MD Resident Physician, Department of Psychiatry, University of Michigan Medical School

Michael Seyffert, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Psychiatry and the Law, Child Neurology Society, American Academy of Sleep Medicine, Society for the Study of Psychiatry and Culture

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Amy Kao, MD Attending Neurologist, Children's National Medical Center

Amy Kao, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, Child Neurology Society

Disclosure: Have stock from Cellectar Biosciences; have stock from Varian medical systems; have stock from Express Scripts.

Additional Contributors

Robert Stanley Rust, Jr, MD, MA Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia School of Medicine; Chair-Elect, Child Neurology Section, American Academy of Neurology

Robert Stanley Rust, Jr, MD, MA is a member of the following medical societies: Child Neurology Society, Society for Pediatric Research, American Headache Society, International Child Neurology Association, American Academy of Neurology, American Epilepsy Society, American Neurological Association

Disclosure: Nothing to disclose.


The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Marcio Sotero de Menezes, MD, to the development and writing of the source article.

  1. Patry G, Lyagoubi S, Tassinari CA. Subclinical "electrical status epilepticus" induced by sleep in children. A clinical and electroencephalographic study of six cases. Arch Neurol. 1971 Mar. 24(3):242-52. [Medline].

  2. Feekery CJ, Parry-Fielder B, Hopkins IJ. Landau-Kleffner syndrome: six patients including discordant monozygotic twins. Pediatr Neurol. 1993 Jan-Feb. 9(1):49-53. [Medline].

  3. Kotagal P. Secondary epileptogenesis [editorial]. J Clin Neurophysiol. 1997 Mar. 14(2):89. [Medline].

  4. Solomon GE, Carson D, Pavlakis S, et al. Intracranial EEG monitoring in Landau-Kleffner syndrome associated with left temporal lobe astrocytoma. Epilepsia. 1993 May-Jun. 34(3):557-60. [Medline].

  5. Otero E, Cordova S, Diaz F, et al. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia. 1989 Sep-Oct. 30(5):569-72. [Medline].

  6. Perniola T, Margari L, Buttiglione M, et al. A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease. Epilepsia. 1993 May-Jun. 34(3):551-6. [Medline].

  7. Primavera A, Gianelli MV, Bandini F. Aphasic status epilepticus in multiple sclerosis. Eur Neurol. 1996. 36(6):374-7. [Medline].

  8. Kang HC, Kim HD, Lee YM. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol. 2006 Aug. 35(2):158-61. [Medline].

  9. Huppke P, Kallenberg K, Gartner J. Perisylvian polymicrogyria in Landau-Kleffner syndrome. Neurology. 2005 May 10. 64(9):1660. [Medline].

  10. Kaga M, Inagaki M, Ohta R. Epidemiological study of Landau-Kleffner syndrome (LKS) in Japan. Brain Dev. 2013 May 21. [Medline].

  11. Soprano AM, Garcia EF, Caraballo R, Fejerman N. Acquired epileptic aphasia: neuropsychologic follow-up of 12 patients. Pediatr Neurol. 1994 Oct. 11(3):230-5. [Medline].

  12. Robinson RO, Baird G, Robinson G, Simonoff E. Landau-Kleffner syndrome: course and correlates with outcome. Dev Med Child Neurol. 2001 Apr. 43(4):243-7. [Medline].

  13. Morrell F. Electrophysiology of CSWS in Landau-Kleffner syndrome. In: Beaumanoir A, Bureau M, Deona T, Mira L, Tassinari CA, eds. Continuous Spikes and Waves During Slow Sleep Electrical Status Epilepticus During Slow Wave Sleep. London, England: John Libbey; 1995. 77-90.

  14. Duran MH, Guimaraes CA, Medeiros LL, Guerreiro MM. Landau-Kleffner syndrome: long-term follow-up. Brain Dev. 2009 Jan. 31(1):58-63. [Medline].

  15. Beaumanoir A. The Landau-Kleffner syndrome. In: Roger J, Dravet C, Bureau M, Dreifuss FE, Perret A, Wolf P, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence. 2nd ed. London, England: John Libbey Eurotext Ltd. 1992:181-91, 231-43.

  16. Mantovani JF, Landau WM. Acquired aphasia with convulsive disorder: course and prognosis. Neurology. 1980 May. 30(5):524-9. [Medline].

  17. Paquier PF, Van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or acquired aphasia with convulsive disorder: long-term follow-up of six children and a review of the recent literature. Arch Neurol. 1992 Apr. 49(4):354-9. [Medline].

  18. Rossi PG, Parmeggiani A, Posar A, et al. Landau-Kleffner syndrome (LKS): long-term follow-up and links with electrical status epilepticus during sleep (ESES). Brain Dev. 1999 Mar. 21(2):90-8. [Medline].

  19. Rousselle C, Revol M. Relationship between cognitive function and CSWS. In: Beaumanoir A, Bureau M, Deona T, Dreifuss FE, Perret A, Wolf P, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence. 2nd ed. London, England: John Libbey Eurotext Ltd; 1995: 123-33.

  20. Caraballo RH, Astorino F, Cersosimo R, et al. Atypical evolution in childhood epilepsy with occipital paroxysms (Panayiotopoulos type). Epileptic Disord. 2001 Sep. 3(3):157-62. [Medline].

  21. Ferrie CD, Koutroumanidis M, Rowlinson S, et al. Atypical evolution of Panayiotopoulos syndrome: a case report. Epileptic Disord. 2002 Mar. 4(1):35-42. [Medline].

  22. Scheffer IE, Jones L, Pozzebon M, et al. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann Neurol. 1995 Oct. 38(4):633-42. [Medline].

  23. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics. 1997 Apr. 99(4):560-6. [Medline]. [Full Text].

  24. Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013 Aug 28. 45(9):1061-6. [Medline].

  25. Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet. 2013 Aug 28. 45(9):1073-6. [Medline].

  26. Rapin I. Acquired aphasia in children [editorial]. J Child Neurol. 1995 Jul. 10(4):267-70. [Medline].

  27. Rapin I. Autistic regression and disintegrative disorder: how important the role of epilepsy?. Semin Pediatr Neurol. 1995 Dec. 2(4):278-85. [Medline].

  28. Luat AF, Chugani HT, Asano E. Episodic receptive aphasia in a child with Landau-Kleffner Syndrome: PET correlates. Brain Dev. 2006 Oct. 28(9):592-6. [Medline].

  29. Nickels K, Wirrell E. Electrical status epilepticus in sleep. Semin Pediatr Neurol. 2008 Jun. 15(2):50-60. [Medline].

  30. Tassinari CA, Cantalupo G, Rios-Pohl L, Giustina ED, Rubboli G. Encephalopathy with status epilepticus during slow sleep: "the Penelope syndrome". Epilepsia. 2009 Aug. 50 Suppl 7:4-8. [Medline].

  31. Paetau R, Kajola M, Korkman M, et al. Landau-Kleffner syndrome: epileptic activity in the auditory cortex. Neuroreport. 1991 Apr. 2(4):201-4. [Medline].

  32. Paetau R. Magnetoencephalography in Landau-Kleffner syndrome. Epilepsia. 2009 Aug. 50 Suppl 7:51-4. [Medline].

  33. Pascual-Castroviejo I, Lopez Martin V, Martinez Bermejo A, Perez Higueras A. Is cerebral arteritis the cause of the Landau-Kleffner syndrome? Four cases in childhood with angiographic study. Can J Neurol Sci. 1992 Feb. 19(1):46-52. [Medline].

  34. Arts WF, Aarsen FK, Scheltens-de Boer M, Catsman-Berrevoets CE. Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins. Epilepsia. 2009 Aug. 50 Suppl 7:55-8. [Medline].

  35. Riviello JJ. The Boston Children's Hospital experience with ESES and LKS course. Paper presented at: Annual Meeting of the American Epilepsy Society; December 2006; San Diego, California.

  36. Kossoff EH, Boatman D, Freeman JM. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav. 2003 Oct. 4(5):571-5. [Medline].

  37. von Stülpnagel C, Kluger G, Leiz S, Holthausen H. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood. Epilepsy Behav. 2010 Feb. 17(2):193-198. [Medline].

  38. Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. Handb Clin Neurol. 2013. 111:635-40. [Medline].

  39. Kramer U, Sagi L, Goldberg-Stern H, Zelnik N, Nissenkorn A, Ben-Zeev B. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia. 2009 Jun. 50(6):1517-24. [Medline].

  40. Glauser TA, Olberding LS, Titanic MK, Piccirillo DM. Felbamate in the treatment of acquired epileptic aphasia. Epilepsy Res. 1995 Jan. 20(1):85-9. [Medline].

  41. Buzatu M, Bulteau C, Altuzarra C, Dulac O, Van Bogaert P. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia. 2009 Aug. 50 Suppl 7:68-72. [Medline].

  42. Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain. 1995 Dec. 118 ( Pt 6):1529-46. [Medline].

  43. Sawhney IM, Robertson IJ, Polkey CE, et al. Multiple subpial transection: a review of 21 cases. J Neurol Neurosurg Psychiatry. 1995 Mar. 58(3):344-9. [Medline].

  44. Bergqvist AG, Chee CM, Lutchka LM, Brooks-Kayal AR. Treatment of acquired epileptic aphasia with the ketogenic diet. J Child Neurol. 1999 Nov. 14(11):696-701. [Medline].

  45. Nikanorova M, Miranda MJ, Atkins M, Sahlholdt L. Ketogenic diet in the treatment of refractory continuous spikes and waves during slow sleep. Epilepsia. 2009 May. 50(5):1127-31. [Medline].

  46. Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia. 1990 Nov-Dec. 31(6):768-77. [Medline].

  47. Okuyaz C, Aydin K, Gucuyener K, Serdaroglu A. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol. 2005 Jan. 32(1):64-7. [Medline].

  48. Van Hirtum-Das M, Licht EA, Koh S. Children with ESES: variability in the syndrome. Epilepsy Res. 2006 Aug. 70 Suppl 1:S248-58. [Medline].

Table 1. Long-Term Follow-up of Acquired Epileptic Aphasia
Study Number of Patients Mean Follow-up, y Number of Patients with Normal or Mild Language Problems
Soprano et al[11] (1994) 12 8 3
Mantovani and Landau[16] (1980) 9 22 6
Paquier[17] (1992) 6 8.1 3
Rossi[18] (1999) 11 9.7 2
Robinson et al[12] (2001) 18 5.6 3
Duran et al[14] (2009) 7 9.5 1
Total 63   18 (28.6%)
Table 2. Epileptiform EEG Findings in Autism, Dysphasia, and Epilepsy
Source Diagnosis Number of Patients Number of Patients with EEGs Patients with Abnormal EEGs (%)
Tuchman et al (1991) Autism with epilepsy 42 40 75
Autism without epilepsy 160 139 8
Dysphasia with epilepsy 19 19 58
Dysphasia without epilepsy 218 66 9
Tuchman and Rapin[23] (1997) PDD or autism 585 392* NA
With epilepsy NA 66 59
Without epilepsy NA 66 59
Without epilepsy but with history of regression NA 155 14
Without epilepsy and without history of regression NA 364 6
EEG(s) = electroencephalogram(s); NA = not applicable; PDD = personality developmental disorder.

* Sleep EEGs.

Diagnosis Deterioration EEG Patterns
Autistic epileptiform regression Expressive language, RL, S, verbal and nonverbal communication Centrotemporal spikes
Autistic regression Expressive language, RL, S, verbal and nonverbal communication Normal
Acquired epileptic aphasia RL, possibly behavioral Left or right temporal or parietal spikes, possibly ESES
Acquired expressive epileptic aphasia Expressive language, oromotor apraxia Centrotemporal spikes
ESES Expressive language, RL, possibly behavioral ESES
Developmental dysphasia (developmental expressive language disease) No; lack of expressive language acquisition Temporal or parietal spikes
Disintegrative epileptiform disorder Expressive language, RL, S, verbal and nonverbal communication, possibly behavioral ESES
EEG = electroencephalographic; ESES = electrical status epilepticus of sleep; RL = receptive language; S = sociability.

* Continuous spike and wave of slow-wave sleep (>85% of slow-wave sleep).

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.